我要投票 玉林YULIN在医疗器械行业中的票数:691
· 外 推 电 报 ·
2026-01-09 08:15:25 星期五

【玉林YULIN是哪个国家的品牌?】

玉林YULIN是什么牌子?「玉林YULIN」是 广西玉林制药集团有限责任公司 旗下著名品牌。该品牌发源于广西玉林市,由创始人高海恩在1985-11-28期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力玉林YULIN品牌出海!将品牌入驻外推网,定制玉林YULIN品牌推广信息,可以显著提高玉林YULIN产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

始于1956年,康臣药业集团旗下,中华老字号,拥有正骨水/湿毒清胶囊/鸡骨草胶囊/云香精/三七伤药胶等知名药品,以中药为主,生产胶囊剂/酊剂等药物的高新技术企业


广西玉林制药集团是康臣药业集团(1681.HK)的成员企业之一,前身为创立于1956年的玉林制药厂,是一家以中成药和天然药物研发、生产、销售为主业的中药制药企业。玉林制药的业务已拓展到中药饮片加工、中药材种植与经营、药用空心胶囊制造、国内国际贸易等领域。

公司主要产品有正骨水、湿毒清胶囊、鸡骨草胶囊、云香精、银蒲解毒片、珍黄胶囊(珍黄丸)、三七伤药胶囊等9个剂型74个品种,其中国家中药保护品种有正骨水、湿毒清胶囊、鸡骨草胶囊等12个品种。公司产品质量可靠,疗效确切,品牌知名度高。

公司拥有强大的中药综合处理及制剂能力,其中胶囊剂18.5亿粒/年,片剂7.6亿片/年,酊剂76万升/年。拥有健全的质量保障体系,于1996年通过澳大利亚TGA的GMP认证,并连续八次通过复查,2003年整体通过国家GMP认证。

公司产销规模达5亿多元,经营稳健。公司具有自营进出口权,出口产品50种,远销30多个国家和地区,年出口创汇近300万美元。

公司始终坚持以市场为导向,项目为载体,加强产学研的联合,具备良好的产品研发能力和对外技术合作基础,拥有各类专业人员360多人。

长期以来,玉林制药始终秉承“珍爱生命、关注健康”的经营宗旨,为人类创造健康、为股东创造利益、为员工创造前途、为社会创造效益。作为康臣药业集团的成员企业,玉林制药将不断丰富和优化产品结构,强化质量控制,创新产品研发和营销模式,与客户合作共赢。


英文翻译:In 1956, the Chinese time-honored brand of Kang Chen Pharmaceutical Group has the famous medicines such as bone setting water / damp poison capsule / chicken bone grass capsule / cloud essence / 37 adhesive, etc. the high-tech pharmaceutical enterprise, which is mainly traditional Chinese medicine, produces capsules / tincture, and so on. The Guangxi Yulin Pharmaceutical Group is one of the members of Kang Chen Pharmaceutical Group (1681.HK), formerly known as the Yulin pharmaceutical factory founded in 1956. Is a traditional Chinese medicine pharmaceutical enterprise with R & D, production and sales of proprietary Chinese medicine and natural medicine as its main business. Yulin pharmaceutical's business has expanded to the processing of Chinese herbal pieces, the planting and management of Chinese herbal medicines, the manufacturing of medicinal hollow capsules, domestic and international trade and other fields. The main products of China are 74 kinds of 9 formulations: "bone setting water", "damp poison capsule", "chicken bone grass capsule", "Yun Xiang essence", "yinpu Jiedu Tablets", "Zhen Huang capsule" (Zhen Huang pill), and "37 capsule". Among them, 12 kinds of Chinese medicine protection varieties are bone setting water, damp poison capsule, chicken bone grass capsule and so on. The company has reliable product quality, precise curative effect and high brand awareness. The company has strong comprehensive treatment and preparation capacity of traditional Chinese medicine, including 1.85 billion capsules / year, 76000 tablets / year and 760000 tinctures / year. It has a sound quality assurance system, passed the GMP certification of TGA in Australia in 1996, passed the review eight times in succession, and passed the national GMP certification as a whole in 2003. The production and marketing scale of the company is more than 500 million yuan, and the operation is stable. The company has the right of self import and export, 50 kinds of export products, exported to more than 30 countries and regions, with an annual export earning of nearly 3 million US dollars. The company always adheres to the market-oriented, project-based, strengthening the combination of production, learning and research, with good product R & D capabilities and foreign technical cooperation foundation, with more than 360 professionals. For a long time, Yulin pharmaceutical has always adhered to the business tenet of "cherish life and pay attention to health", creating health for human beings, interests for shareholders, future for employees and benefits for society. As a member enterprise of Kangchen Pharmaceutical Group, Yulin pharmaceutical will continue to enrich and optimize product structure, strengthen quality control, innovate product R & D and marketing mode, and cooperate with customers for win-win results.

本文链接: https://www.waitui.com/brand/b4dba7440.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

华纳兄弟探索公司拒绝派拉蒙,坚持与Netflix的交易

华纳兄弟探索公司敦促股东拒绝派拉蒙的敌意收购,并重申其将工作室和流媒体资产出售给Netflix的协议是更优报价,且完成路径更明确。(新浪财经)

16分钟前

Grok因涉性图像面临审查

埃隆·马斯克麾下未上市企业xAI在其Grok模型被用于生成涉性图像(包括未成年人图像)后受到抨击,这引发了监管机构对该与X平台集成的工具的调查和政策质疑。(新浪财经)

16分钟前

保险公司发债规模连续三年超千亿元,多重因素推动

连续三年,保险公司发行债券规模超千亿元。刚刚过去的2025年,23家保险公司发债规模合计达1042亿元。业内人士普遍认为,这背后有多重推动因素——低利率周期下,保险公司普遍面临较高的资本补充需求;利率下行,发债成本更低,险企有动力发新债置换旧债;也有险企希望在利率低位时融资以进一步夯实资本实力、增厚发展安全垫。另外,在逆周期监管思路下,保险公司发债也在一定程度上获得了监管部门的支持。(证券时报)

16分钟前

中信建投:白酒板块迎来周期底部配置机会

36氪获悉,中信建投指出,白酒产业“五底阶段”(政策底、库存底、动销底、批价底、产销底)与资本市场“三低一高”(预期低、估值低、公募持仓低、高分红)共振,结合近期市场策略相继落地,站在春节旺季来临之际,认为本轮白酒调整期拐点将至,资本市场预期先行,白酒板块迎来周期底部配置机会。

16分钟前

CrowdStrike以7.4亿美元收购身份安全初创公司SGNL

网络安全提供商CrowdStrike周四宣布,将以近7.4亿美元的价格收购身份管理初创公司SGNL,以在人工智能网络攻击时代加强防御。该公司表示,此次收购将帮助CrowdStrike的Falcon云安全平台用户更好地管理人员和人工智能身份访问请求以及实时风险。该交易预计将于2027财年第一季度完成。(新浪财经)

16分钟前

本页详细列出关于玉林YULIN的品牌信息,含品牌所属公司介绍,玉林YULIN所处行业的品牌地位及优势。
咨询